Ublituximab for treating relapsing multiple sclerosis

Final draft guidance

Equality impact assessment (downloadable version) (PDF 119 KB)

Committee papers (PDF 4.15 MB)

Final draft guidance (PDF 105 KB)

Final scope (PDF 127 KB)

Equality impact assessment (scoping) (PDF 98 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 267 KB)

Final stakeholder list (PDF 132 KB)

Draft scope post referral (PDF 229 KB)

Draft matrix post referral (PDF 181 KB)